Evidence map›Paper›PMID 25826365›Full record

ArticlePloS one2015

Decreased chloride channel expression in the dorsolateral prefrontal cortex in schizophrenia.

Courtney R Sullivan, Adam J Funk, Dan Shan, Vahram Haroutunian, Robert E McCullumsmith

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Silencing KCC2 in mouse dorsal hippocampus compromises spatial and contextual memory.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Courtney R SullivanUniversity of Cincinnati College of Medicine, Neuroscience Graduate Program, Cincinnati, Ohio, United States of America; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio, United States of America.
Adam J FunkDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio, United States of America.
Dan ShanDepartment of Nephrology, University of Alabama Birmingham, Birmingham, Alabama, United States of America.
Vahram HaroutunianDepartment of Psychiatry, Mount Sinai School of Medicine, New York, New York, United States of America; James J Peters Veterans Affairs Medical Center, New York, New York, United States of America.
Robert E McCullumsmithDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio, United States of America.
University of Cincinnati · USJames J. Peters VA Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Cincinnati Medical Center · US

Funding

White Matter Abnormalities in SchizophreniaP50MH066392 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BUXBAUM, JOSEPH D. · 2002 to 2012
$18.6M
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCEST32NS007453 · NINDS · UNIVERSITY OF CINCINNATI · PI HERMAN, JAMES P · 1997 to 2025
$4.0M
Cortico-thalamic Glutamate/GABA mRNA in schizophreniaR01MH064673 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI HAROUTUNIAN, VAHRAM · 2003 to 2012
$3.4M
Defects of subcellular glutamate transporter localization in schizophreniaR01MH094445 · NIMH · UNIVERSITY OF CINCINNATI · PI MCCULLUMSMITH, ROBERT E · 2011 to 2015
$1.7M
Glutamate Transporter Expression in SchizophreniaK08MH074016 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MCCULLUMSMITH, ROBERT E · 2006 to 2010
$872k
NIMH NIH HHS K08 MH074016NIMH NIH HHS MH064673NIMH NIH HHS MH066392NIMH NIH HHS MH074016NIMH NIH HHS MH094445NIMH NIH HHS P50 MH066392NIMH NIH HHS R01 MH064673NIMH NIH HHS R01 MH094445NINDS NIH HHS T32 NS007453
6 · The paper itself

Abstract

Alterations in GABAergic neurotransmission are implicated in several psychiatric illnesses, including schizophrenia. The Na-K-Cl and K-Cl cotransporters regulate intracellular chloride levels. Abnormalities in cotransporter expression levels could shift the chloride electrochemical gradient and impair GABAergic transmission. In this study, we performed Western blot analysis to investigate whether the Na-K-Cl and K-Cl cotransporter protein is abnormally expressed in the dorsal lateral prefrontal cortex and the anterior cingulate cortex in patients with schizophrenia versus a control group. We found decreased K-Cl cotransporter protein expression in the dorsal lateral prefrontal cortex, but not the anterior cingulate cortex, in subjects with schizophrenia, supporting the hypothesis of region level abnormal GABAergic function in the pathophysiology of schizophrenia. Subjects with schizophrenia off antipsychotic medication at the time of death had decreased K-Cl cotransporter protein expression compared to both normal controls and subjects with schizophrenia on antipsychotics. Our results provide evidence for KCC2 protein abnormalities in schizophrenia and suggest that antipsychotic medications might reverse deficits of this protein in the illness.

Indexed as

Chloride ChannelsFemaleHumansMalePrefrontal CortexSchizophreniaChloride Channels

Identifiers

PMID25826365
PMCPMC4380350
OpenAlexW1982835091

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.